Welcome to LookChem.com Sign In|Join Free

CAS

  • or
6-(4-hydroxyphenyl)-3,9-dimethoxy-5H-indeno[1,2-c] isoquinoline-5,11(6H)-diketone is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1225021-05-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1225021-05-5 Structure
  • Basic information

    1. Product Name: 6-(4-hydroxyphenyl)-3,9-dimethoxy-5H-indeno[1,2-c] isoquinoline-5,11(6H)-diketone
    2. Synonyms: 6-(4-hydroxyphenyl)-3,9-dimethoxy-5H-indeno[1,2-c] isoquinoline-5,11(6H)-diketone
    3. CAS NO:1225021-05-5
    4. Molecular Formula:
    5. Molecular Weight: 399.403
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1225021-05-5.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 6-(4-hydroxyphenyl)-3,9-dimethoxy-5H-indeno[1,2-c] isoquinoline-5,11(6H)-diketone(CAS DataBase Reference)
    10. NIST Chemistry Reference: 6-(4-hydroxyphenyl)-3,9-dimethoxy-5H-indeno[1,2-c] isoquinoline-5,11(6H)-diketone(1225021-05-5)
    11. EPA Substance Registry System: 6-(4-hydroxyphenyl)-3,9-dimethoxy-5H-indeno[1,2-c] isoquinoline-5,11(6H)-diketone(1225021-05-5)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1225021-05-5(Hazardous Substances Data)

1225021-05-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1225021-05-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,5,0,2 and 1 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1225021-05:
(9*1)+(8*2)+(7*2)+(6*5)+(5*0)+(4*2)+(3*1)+(2*0)+(1*5)=85
85 % 10 = 5
So 1225021-05-5 is a valid CAS Registry Number.

1225021-05-5Downstream Products

1225021-05-5Relevant articles and documents

Design, synthesis and evaluation of 6-aryl-indenoisoquinolone derivatives dual targeting ERα and VEGFR-2 as anti-breast cancer agents

Tang, Zhichao,Wu, Chengzhe,Wang, Tianlin,Lao, Kejing,Wang, Yejun,Liu, Linyi,Muyaba, Moses,Xu, Pei,He, Conghui,Luo, Guoshun,Qian, Zhouyang,Niu, Shaoxiong,Wang, Lijun,Wang, Ying,Xiao, Hong,You, Qidong,Xiang, Hua

, p. 328 - 339 (2016)

The estrogen receptors have played important roles in breast cancer development and progression. Selective estrogen receptor modulators, such as Tamoxifen, have showed great benefits in the treatment and prevention of breast cancer. But the disadvantages of induction of endometrial cancer and drug resistance have limited their use. Multiple ligand which act at multiple biomolecular targets may exert favorable advantages of improved efficacy with lower incidence of side effects. In this work, we described the synthesis and evaluation of a series of 6-aryl-indenoisoquinolone derivatives as dual ERα and VEGFR-2 inhibitors. These compounds presented good ERα binding affinity and ERα antagonistic activity, as well as potent VEGFR-2 inhibitory potency. They also possessed excellent anti-proliferative activities against MCF-7, MDA-MB-231, Ishikawa and HUVEC cell lines. Further investigation of selective compound 21c showed that it was able to inhibit the activation of VEGFR-2 and the signaling transduction of Raf-1/MAPK/ERK pathway in MCF-7 cells.

INDENOISOQUINOLINONE DERIVATIVES, MANUFACTURING METHOD AND MEDICAL USE THEREOF

-

, (2013/04/13)

Indenoisoquinolinone derivatives (I), the manufacturing method and the medical use thereof, which belong to pharmaceutical chemistry and organic chemistry field, are disclosed. These compounds can be used for treating several medical symptoms related to postmenopausal syndrome, uterine fibers deterioration and aortic smooth muscle cells proliferation, especially ER-(+) depend breast cancer. Meanwhile, these compounds can also be used for treating glioma and lung cancer, and have inhibiting effect on tumor metastasis effect on tumor metastasis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1225021-05-5